Physician profile
Thomas Drames
NPI 1003049610
$9,848.18
in general payments reported to CMS, 2019-2025
38 companies · $1,440 in 2025
The $1,440 reported for 2025 was more than what 83% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $975 · 2020: $1,019 · 2021: $885 · 2022: $1,272 · 2023: $1,988 · 2024: $2,270 · 2025: $1,440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,540 · Education: $158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,540.15 |
| Education | $157.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,814.57 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,828.67 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $521.13 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Insmed, INC. | $437.81 | 2019-2025 | Arikayce |
| Mylan Specialty L.P. | $423.07 | 2019-2024 | Yupelri |
| Genentech USA, INC. | $417.41 | 2019-2025 | Xolair |
| Jazz Pharmaceuticals INC. | $379.29 | 2019-2025 | |
| Amgen INC. | $303.89 | 2022-2025 | Tezspire |
| Harmony Biosciences LLC | $266.39 | 2020-2025 | Wakix |
| Genzyme Corporation | $246.13 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $237.76 | 2019-2025 | Dupixent |
| Electromed, INC. | $187.84 | 2022-2024 | Smartvest |
| Inspire Medical Systems, INC. | $179.36 | 2023-2025 | Inspire |
| Verona Pharma, INC. | $160.98 | 2025 | Ohtuvayre |
| Axsome Therapeutics, INC. | $156.19 | 2023-2025 | Sunosi |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Drames listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.